![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
North China Pharmaceutical Co., Ltd. Shijiazhuang Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Phenoxymethylpenicillin potassium, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2006-019 - Rev 00
This Chemical Type CEP, issued on November 26, 2008, remains in force until November 04, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 149 associated with this CEP further emphasizes